Therefore, special attention should be paid to repeated blood tests for routine, liver function, and if thrombocytopenia, neutropenia, and liver function abnormalities occur, timely treatment with recombinant human interleukin 11, granulocyte colony-stimulating factor injection, and hepatoprotective drugs should be administered. This evidence concerns the gene CSF3 and neutropenia.